OSF Little Company of Mary Medical Center is a hospital in Evergreen Park, Illinois, USA. The hospital was founded on January 19, 1930, by the Sisters of the Little Company of Mary and serves much of the southwest side of Chicago.

During the past decade, Little Company of Mary Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Little Company of Mary Hospital" #1 sponsor was "SWOG Cancer Research Network" with 4 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Xoft, Inc." with 3 trials sponsored, "Johns Hopkins University" with 1 trials sponsored and "Vertos Medical, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Little Company of Mary Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "Duke University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Little Company of Mary Hospital" are "Breast Cancer" (4 trials), "Breast Carcinoma" (2 trials), "Anatomic Stage I Breast Cancer AJCC v8" (1 trials), "Anatomic Stage IA Breast Cancer AJCC v8" (1 trials) and "Anatomic Stage IB Breast Cancer AJCC v8" (1 trials). Many other conditions were trialed in "Little Company of Mary Hospital" in a lesser frequency.

Most popular intervention types in "Little Company of Mary Hospital" are "Other" (6 trials), "Drug" (4 trials), "Radiation" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "Aspirin" (1 trials), "Biospecimen Collection" (1 trials), "Chemotherapy" (1 trials) and "Electronic brachytherapy (Axxent System)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Little Company of Mary Hospital" are 6 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Little Company of Mary Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Little Company of Mary Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Little Company of Mary Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".